Quipt Home Medical Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Quipt Home Medical stock have an average target of 3.83, with a low estimate of 3.65 and a high estimate of 4.00. The average target predicts an increase of 5.22% from the current stock price of 3.64.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$3.65	$3.83	$4.00	$4.00
Change	+0.27%	+5.22%	+9.89%	+9.89%

* Price targets were last updated on Dec 17, 2025.

Analyst Ratings

The average analyst rating for Quipt Home Medical stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Richard Close Canaccord Genuity	Canaccord Genuity	Hold Maintains $2.3 → $3.65	Hold	Maintains	$2.3 → $3.65	+0.27%	Dec 17, 2025
Richard Close Canaccord Genuity	Canaccord Genuity	Hold Maintains $1.7 → $2.3	Hold	Maintains	$1.7 → $2.3	-36.81%	Aug 19, 2025
Bill Sutherland Benchmark	Benchmark	Strong Buy Maintains $6 → $4	Strong Buy	Maintains	$6 → $4	+9.89%	May 14, 2025
Richard Close Canaccord Genuity	Canaccord Genuity	Strong Buy → Hold Downgrades $4 → $1.7	Strong Buy → Hold	Downgrades	$4 → $1.7	-53.30%	May 13, 2025
Bill Sutherland Benchmark	Benchmark	Strong Buy Maintains $7 → $6	Strong Buy	Maintains	$7 → $6	+64.84%	Dec 20, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

314.80M

from 245.36M

28.30%

from 245.36M

Revenue Next Year

320.42M

from 314.80M

1.79%

from 314.80M

EPS This Year

-0.18

from -0.25

EPS Next Year

-0.29

from -0.18

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025	Sep 30, 2026	Sep 30, 2027
Revenue	94.39M	127.64M	211.68M	245.92M	245.36M	314.80M	320.42M
Revenue Growth	29.95%	35.22%	65.84%	16.18%	-0.23%	28.30%	1.79%
EPS	-0.20	0.13	-0.07	-0.16	-0.25	-0.18	-0.29
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	327.0M	330.8M
Avg	314.8M	320.4M
Low	299.5M	307.0M

Revenue Growth

Revenue Growth	2026	2027
High	33.3%	5.1%
Avg	28.3%	1.8%
Low	22.1%	-2.5%

EPS Forecast

EPS	2026	2027
High	0.11	-0.29
Avg	-0.18	-0.29
Low	-0.44	-0.27

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.